Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Alama · SciRah

Researcher profile · Semantic Scholar

A. Alama

Share profile

A. Alama — researcher profile on SciRah

h-index: 31
Works: 143
Citations: 2,841

Most-cited papers

Organometallic compounds in oncology: implications of novel organotins as antitumor agents.
A. Alama, B. Tasso, F. Novelli, F. Sparatore
2009Drug Discovery Today247 citations
Semantic Scholar
The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients
M. G. Dal Bello, R. Filiberti, A. Alama, A. Orengo +12 more
2019Journal of Translational Medicine177 citations Open access
Semantic Scholar
Exosomes: a new horizon in lung cancer.
I. Vanni, A. Alama, F. Grossi, M. G. Dal Bello +1 more
2017Drug Discovery Today104 citations
Semantic Scholar
Radiomic Detection of EGFR Mutations in NSCLC
G. Rossi, E. Barabino, A. Fedeli, G. Ficarra +14 more
2020Cancer Research92 citations Open access
Semantic Scholar
Caveolin‐1 is essential for metformin inhibitory effect on IGF1 action in non‐small‐cell lung cancer cells
Barbara Salani, Sara Maffioli, Meriem Hamoudane, A. Parodi +6 more
2012The FASEB Journal77 citations
Semantic Scholar
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer
S. Ottonello, C. Genova, Irene Cossu, V. Fontana +15 more
2020Frontiers in Immunology76 citations Open access
Semantic Scholar
Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System
A. Truini, A. Alama, M. G. Dal Bello, S. Coco +6 more
2014Frontiers in Oncology76 citations Open access
Semantic Scholar
Understanding the checkpoint blockade in lung cancer immunotherapy.
M. G. Dal Bello, A. Alama, S. Coco, I. Vanni +1 more
2017Drug Discovery Today62 citations
Semantic Scholar
Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer
S. E. Rebuzzi, L. Zullo, G. Rossi, M. Grassi +11 more
2021International Journal of Molecular Sciences56 citations Open access
Semantic Scholar
Characterization of apoptosis induced by marine natural products in non small cell lung cancer A549 cells
A. Catassi, A. Cesario, D. Arzani, P. Menichini +6 more
2006Cellular and Molecular Life Sciences (CMLS)55 citations Open access
Semantic Scholar
Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab
A. Alama, S. Coco, C. Genova, G. Rossi +11 more
2019Journal of Clinical Medicine52 citations Open access
Semantic Scholar
Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy
S. Coco, A. Alama, I. Vanni, V. Fontana +10 more
2017International Journal of Molecular Sciences46 citations Open access
Semantic Scholar
Circulating Tumor DNA Reflects Tumor Metabolism Rather Than Tumor Burden in Chemotherapy-Naive Patients with Advanced Non–Small Cell Lung Cancer: 18F-FDG PET/CT Study
S. Morbelli, A. Alama, Giulia Ferrarazzo, S. Coco +13 more
2017Journal of Nuclear Medicine44 citations Open access
Semantic Scholar
Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition
S. Coco, A. Truini, A. Alama, M. G. Dal Bello +10 more
2015Targeted oncology44 citations
Semantic Scholar
Next generation sequencing in non-small cell lung cancer: new avenues toward the personalized medicine.
S. Coco, A. Truini, I. Vanni, M. G. Dal Bello +9 more
2015Current Drug Targets43 citations
Semantic Scholar
Inhibition of the Nicotinic Acetylcholine Receptors by Cobra Venom α-Neurotoxins: Is There a Perspective in Lung Cancer Treatment?
A. Alama, C. Bruzzo, Z. Cavalieri, Alessandra Forlani +3 more
2011PLoS ONE41 citations Open access
Semantic Scholar
Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer.
A. Alama, A. Truini, S. Coco, C. Genova +1 more
2014Drug Discovery Today38 citations
Semantic Scholar
Role of microRNAs in malignant mesothelioma
A. Truini, S. Coco, A. Alama, C. Genova +7 more
2014Cellular and Molecular Life Sciences38 citations Open access
Semantic Scholar
Pemetrexed for the treatment of non-small cell lung cancer
C. Genova, E. Rijavec, A. Truini, S. Coco +8 more
2013Expert Opinion on Pharmacotherapy37 citations
Semantic Scholar
Targeting cancer-initiating cell drug-resistance: a roadmap to a new-generation of cancer therapies?
A. Alama, A. Orengo, S. Ferrini, R. Gangemi
2012Drug Discovery Today37 citations
Semantic Scholar
Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform
I. Vanni, S. Coco, A. Truini, M. Rusmini +10 more
2015International Journal of Molecular Sciences36 citations Open access
Semantic Scholar
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study
A. Bonaventura, F. Grossi, F. Carbone, A. Vecchié +16 more
2019Cancer Immunology and Immunotherapy34 citations Open access
Semantic Scholar
Afatinib and Erlotinib in the treatment of squamous-cell lung cancer
M. Tagliamento, C. Genova, E. Rijavec, G. Rossi +6 more
2018Expert Opinion on Pharmacotherapy32 citations
Semantic Scholar
Expression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I–III Non-Small Cell Lung Cancer
F. Grossi, M. G. Dal Bello, S. Salvi, R. Puzone +11 more
2015Disease Markers32 citations Open access
Semantic Scholar
Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
C. Genova, Roberta Tasso, Alessandra Rosa, G. Rossi +21 more
2023Cells30 citations Open access
Semantic Scholar
Targeting alpha7-nicotinic receptor for the treatment of pleural mesothelioma.
A. Catassi, L. Paleari, D. Servent, F. Sessa +15 more
2008European Journal of Cancer30 citations
Semantic Scholar
Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma
A. Truini, S. Coco, E. Nadal, C. Genova +17 more
2017OncoTarget29 citations Open access
Semantic Scholar
Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples
S. Bonfiglio, I. Vanni, Valeria Rossella, A. Truini +9 more
2016BMC Cancer28 citations Open access
Semantic Scholar
Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab
C. Genova, S. Boccardo, M. Mora, E. Rijavec +12 more
2019Journal of Clinical Medicine27 citations Open access
Semantic Scholar
Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds
M. Tagliamento, C. Genova, G. Rossi, S. Coco +5 more
2019Expert Opinion on Investigational Drugs27 citations
Semantic Scholar
Glutathione S‐transferase P1‐1 as a target for mesothelioma treatment
A. De Luca, Francesca Pellizzari Tregno, A. Sau, A. Pastore +5 more
2013Cancer Science26 citations Open access
Semantic Scholar
Significance of cyclin D1 expression in meningiomas: a preliminary study.
A. Alama, F. Barbieri, R. Spaziante, C. Bruzzo +3 more
2007Journal of clinical neuroscience24 citations
Semantic Scholar
The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer
G. Rossi, A. Alama, C. Genova, E. Rijavec +6 more
2018Expert Opinion on Pharmacotherapy23 citations
Semantic Scholar
Oral vinorelbine in the treatment of non-small-cell lung cancer
G. Barletta, C. Genova, E. Rijavec, G. Burrafato +11 more
2014Expert Opinion on Pharmacotherapy23 citations
Semantic Scholar
Immunotherapy-chemotherapy combinations for non-small cell lung cancer: current trends and future perspectives
E. Cella, L. Zullo, Silvia Marconi, G. Rossi +12 more
2022Expert Opinion on Biological Therapy22 citations
Semantic Scholar
Role of immunotherapy in the treatment of advanced non-small-cell lung cancer.
E. Rijavec, C. Genova, A. Alama, G. Barletta +8 more
2014Future Oncology22 citations
Semantic Scholar
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer
F. Carbone, F. Grossi, A. Bonaventura, A. Vecchié +16 more
2019Clinical and Experimental Metastasis21 citations
Semantic Scholar
In vitro cytotoxic activity of tri-n-butyltin(IV)lupinylsulfide hydrogen fumarate (IST-FS 35) and preliminary antitumor activity in vivo
A. Alama, M. Viale, M. Cilli, C. Bruzzo +3 more
2009Investigational new drugs21 citations
Semantic Scholar
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab
C. Genova, Silvia Marconi, G. Chiorino, F. Guana +24 more
2024Clinical and Experimental Medicine (Testo stampato)18 citations Open access
Semantic Scholar
Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors
M. D. Dal Bello, A. Alama, G. Barletta, S. Coco +9 more
2015International Journal of Cancer18 citations Open access
Semantic Scholar
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy
M. Grottoli, P. Carrega, L. Zullo, C. Dellepiane +15 more
2022Cancers16 citations Open access
Semantic Scholar
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients
Silvia Marconi, M. Croce, G. Chiorino, G. Rossi +22 more
2022Cancers16 citations Open access
Semantic Scholar
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method
C. Bozzetti, F. Quaini, A. Squadrilli, M. Tiseo +21 more
2015PLoS ONE15 citations Open access
Semantic Scholar
Belagenpumatucel-L for the treatment of non-small cell lung cancer
E. Rijavec, F. Biello, C. Genova, G. Barletta +10 more
2015Expert Opinion on Biological Therapy15 citations
Semantic Scholar
Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer
G. Gardin, A. Alama, R. Rosso, E. Campora +10 more
2004Breast Cancer Research and Treatment15 citations
Semantic Scholar
Conjugation of Hydroxytyrosol with Other Natural Phenolic Fragments: From Waste to Antioxidants and Antitumour Compounds
Erika Tassano, A. Alama, A. Basso, G. Dondo +3 more
201514 citations
Semantic Scholar
CD133-Positive Cells from Non-Small Cell Lung Cancer Show Distinct Sensitivity to Cisplatin and Afatinib
A. Alama, R. Gangemi, S. Ferrini, G. Barisione +4 more
2015Archivum Immunologiae et Therapiae Experimentalis14 citations
Semantic Scholar
Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma.
S. Coco, A. Truini, I. Vanni, C. Genova +9 more
2015Journal of Thoracic Oncology14 citations Open access
Semantic Scholar
Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural Mesothelioma.
A. Truini, S. Coco, C. Genova, M. Mora +8 more
2016MicroRNA13 citations
Semantic Scholar
Preclinical strategies targeted at non-small-cell lung cancer signalling pathways with striking translational fallout.
R. Favoni, A. Alama
2013Drug Discovery Today13 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Coco×35
Invite
S. Coco — researcher profile on SciRah
C. Genova×33
Invite
C. Genova — researcher profile on SciRah
M. G. Dal Bello×31
Invite
M. G. Dal Bello — researcher profile on SciRah
F. Grossi×29
Invite
F. Grossi — researcher profile on SciRah

×28

Invite

E. Rijavec — researcher profile on SciRah

G. Barletta×22

Invite

G. Barletta — researcher profile on SciRah

Invite

F. Biello — researcher profile on SciRah

Invite

I. Vanni — researcher profile on SciRah

Invite

A. Truini — researcher profile on SciRah

Invite

G. Rossi — researcher profile on SciRah

M. Tagliamento×15

Invite

M. Tagliamento — researcher profile on SciRah

Invite

S. Boccardo — researcher profile on SciRah